Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Long-term results of treatment of malignant carcinoid syndrome with prolonged release Lanreotide (Somatuline Autogel).

Khan MS, El-Khouly F, Davies P, Toumpanakis C, Caplin ME.

Aliment Pharmacol Ther. 2011 Jul;34(2):235-42. doi: 10.1111/j.1365-2036.2011.04693.x. Epub 2011 May 17.

2.

Lanreotide Depot: An Antineoplastic Treatment of Carcinoid or Neuroendocrine Tumors.

Wolin EM, Manon A, Chassaing C, Lewis A, Bertocchi L, Richard J, Phan AT.

J Gastrointest Cancer. 2016 Dec;47(4):366-374. Review.

3.

Somatuline Autogel: an extended release lanreotide formulation.

Lightman S.

Hosp Med. 2002 Mar;63(3):162-5. Review.

PMID:
11933820
4.

Lanreotide autogel(®): a review of its use in the treatment of patients with acromegaly.

Burness CB, Dhillon S, Keam SJ.

Drugs. 2014 Sep;74(14):1673-91. doi: 10.1007/s40265-014-0283-8. Review.

PMID:
25193626
5.

Lanreotide Autogel: a review of its use in the management of acromegaly.

Croxtall JD, Scott LJ.

Drugs. 2008;68(5):711-23. Review.

PMID:
18370450
6.

A critical analysis of clinically available somatostatin analog formulations for therapy of acromegaly.

Murray RD, Melmed S.

J Clin Endocrinol Metab. 2008 Aug;93(8):2957-68. doi: 10.1210/jc.2008-0027. Epub 2008 May 13. Review.

PMID:
18477663
7.

Long-acting formulations of somatostatin analogues.

Anthony LB.

Ital J Gastroenterol Hepatol. 1999 Oct;31 Suppl 2:S216-8. Review.

PMID:
10604134
8.

Octreotide and Lanreotide in Gastroenteropancreatic Neuroendocrine Tumors.

Pokuri VK, Fong MK, Iyer R.

Curr Oncol Rep. 2016 Jan;18(1):7. doi: 10.1007/s11912-015-0492-7. Review.

PMID:
26743514
9.

Somatostatin analogues do not prevent carcinoid crisis.

Guo LJ, Tang CW.

Asian Pac J Cancer Prev. 2014;15(16):6679-83. Review.

10.

Effects of lanreotide SR and Autogel on tumor mass in patients with acromegaly: a systematic review.

Mazziotti G, Giustina A.

Pituitary. 2010;13(1):60-7. doi: 10.1007/s11102-009-0169-z. Review.

PMID:
19189218
11.

Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours.

Modlin IM, Pavel M, Kidd M, Gustafsson BI.

Aliment Pharmacol Ther. 2010 Jan 15;31(2):169-88. doi: 10.1111/j.1365-2036.2009.04174.x. Epub 2009 Oct 21. Review.

12.

Carcinoid tumors.

Boushey RP, Dackiw AP.

Curr Treat Options Oncol. 2002 Aug;3(4):319-26. Review.

PMID:
12074768
13.

Somatostatin analogues in the treatment of endocrine tumors of the gastrointestinal tract.

Arnold R, Wied M, Behr TH.

Expert Opin Pharmacother. 2002 Jun;3(6):643-56. Review. Erratum in: Expert Opin Pharmacother. 2002 Jul;3(7):1029.

PMID:
12472080
14.

Chemotherapy and biotherapy in the treatment of neuroendocrine tumours.

Oberg K.

Ann Oncol. 2001;12 Suppl 2:S111-4. Review.

PMID:
11762335
15.

Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future.

Öberg K, Lamberts SW.

Endocr Relat Cancer. 2016 Dec;23(12):R551-R566. Epub 2016 Oct 3. Review.

16.

Experience with indium-111 and yttrium-90-labeled somatostatin analogs.

Virgolini I, Traub T, Novotny C, Leimer M, Füger B, Li SR, Patri P, Pangerl T, Angelberger P, Raderer M, Burggasser G, Andreae F, Kurtaran A, Dudczak R.

Curr Pharm Des. 2002;8(20):1781-807. Review.

PMID:
12171531
17.

Lanreotide autogel and insulin sensitivity markers: report of 5 acromegalic patients and literature review.

Ertorer ME, Bakiner O, Anaforoglu I, Bozkirli E, Tutuncu NB, Demirag NG.

Neuro Endocrinol Lett. 2007 Dec;28(6):727-33. Review.

PMID:
18063933
18.

[Current treatment of carcinoid tumor].

Elizalde I, Borda F.

Gastroenterol Hepatol. 2002 Oct;25(8):508-13. Review. Spanish. No abstract available.

PMID:
12361534
19.

Telotristat ethyl: a new option for the management of carcinoid syndrome.

Lamarca A, Barriuso J, McNamara MG, Hubner RA, Valle JW.

Expert Opin Pharmacother. 2016 Dec;17(18):2487-2498. Epub 2016 Nov 16. Review.

PMID:
27817224
20.

[Somatostatin analogs in the treatment of carcinoid syndrome: a case report and review of literature].

Junik R, Kamińska A, Kamiński M, Ruprecht Z.

Pol Arch Med Wewn. 2003 Sep;110(3):997-1001. Review. Polish.

PMID:
14699693

Supplemental Content

Support Center